Cécile van Steen
5PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 20, 2024
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison.Cécile van Steen, Lorenzo Celico, Erik Spaepen
|Sep 08, 2022
Current and Future Treatment of Retinitis Pigmentosa.Nancy Cross, Cécile van Steen, Yasmina Zegaoui
|Jun 27, 2022
Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs.Nancy Cross, Cécile van Steen, Yasmina Zegaoui
|May 09, 2022
Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in France.Carlo Lazzaro, Cécile van Steen, Florent Aptel
|Feb 17, 2022
Cost-Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany.Carlo Lazzaro, Cécile van Steen, Stephan Billeit
Pageof 1
Frequent Collaborators
2 joint publications
Carlo Lazzaro
2 joint publications
Luigi Angelillo
2 joint publications
Nancy Cross
1 joint publications
Christopher Kallen
1 joint publications
Florent Aptel
1 joint publications
Cédric Schweitzer
1 joint publications
Tim Hagenacker
1 joint publications
Sven G Meuth
1 joint publications
Tobias Ruck
1 joint publications
A Gordon Smith
